Yi‐Hui Peng

734 total citations
12 papers, 503 citations indexed

About

Yi‐Hui Peng is a scholar working on Molecular Biology, Biochemistry and Biological Psychiatry. According to data from OpenAlex, Yi‐Hui Peng has authored 12 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Biochemistry and 3 papers in Biological Psychiatry. Recurrent topics in Yi‐Hui Peng's work include Tryptophan and brain disorders (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). Yi‐Hui Peng is often cited by papers focused on Tryptophan and brain disorders (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). Yi‐Hui Peng collaborates with scholars based in Taiwan. Yi‐Hui Peng's co-authors include Su‐Ying Wu, Yu‐Sheng Chao, Hsing‐Pang Hsieh, Neeraj Mahindroo, I-Lin Lu, Chuan Shih, Jian‐Sung Wu, Po‐Huang Liang, Keng‐Chang Tsai and Chih‐Jung Kuo and has published in prestigious journals such as Journal of Medicinal Chemistry and ChemMedChem.

In The Last Decade

Yi‐Hui Peng

11 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi‐Hui Peng Taiwan 9 273 144 139 99 71 12 503
Roberto Nuti Italy 11 304 1.1× 101 0.7× 168 1.2× 93 0.9× 33 0.5× 16 628
Bhumika Patel India 12 330 1.2× 93 0.6× 87 0.6× 151 1.5× 48 0.7× 36 724
Markus Muehlbacher Germany 7 445 1.6× 59 0.4× 89 0.6× 48 0.5× 15 0.2× 8 684
Nicola Giacchè Italy 13 283 1.0× 61 0.4× 36 0.3× 142 1.4× 20 0.3× 22 719
Aina Westrheim Ravna Norway 18 449 1.6× 19 0.1× 108 0.8× 53 0.5× 17 0.2× 42 714
Alice Coletti Italy 11 181 0.7× 176 1.2× 16 0.1× 28 0.3× 71 1.0× 24 400
Somi Reddy Majjigapu Switzerland 8 245 0.9× 326 2.3× 19 0.1× 112 1.1× 176 2.5× 12 549
Josh T. Pearson United States 16 205 0.8× 21 0.1× 76 0.5× 29 0.3× 13 0.2× 23 633
Steven M. Winter United States 9 159 0.6× 40 0.3× 101 0.7× 68 0.7× 5 0.1× 13 511
Paola Caria Italy 15 182 0.7× 16 0.1× 50 0.4× 84 0.8× 18 0.3× 44 604

Countries citing papers authored by Yi‐Hui Peng

Since Specialization
Citations

This map shows the geographic impact of Yi‐Hui Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Hui Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Hui Peng more than expected).

Fields of papers citing papers by Yi‐Hui Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐Hui Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Hui Peng. The network helps show where Yi‐Hui Peng may publish in the future.

Co-authorship network of co-authors of Yi‐Hui Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Yi‐Hui Peng. A scholar is included among the top collaborators of Yi‐Hui Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi‐Hui Peng. Yi‐Hui Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Peng, Yi‐Hui, Mu‐Chun Li, Wan-Ching Yen, et al.. (2025). Structure-Based Design of Potent and Selective MerTK Inhibitors by Modulating the Conformation of αC Helix. Journal of Medicinal Chemistry. 68(11). 10877–10896.
2.
Chang, Hsin-Huei, Tsu Hsu, Yi‐Hui Peng, et al.. (2024). Development of Potent and Selective Inhibitors of Methylenetetrahydrofolate Dehydrogenase 2 for Targeting Acute Myeloid Leukemia: SAR, Structural Insights, and Biological Characterization. Journal of Medicinal Chemistry. 67(23). 21106–21125. 4 indexed citations
3.
Peng, Yi‐Hui, Tsu Hsu, Chih‐Hsiang Huang, et al.. (2021). Xanthine Derivatives Reveal an Allosteric Binding Site in Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2). Journal of Medicinal Chemistry. 64(15). 11288–11301. 15 indexed citations
4.
Peng, Yi‐Hui, Ramajayam Kuppusamy, Mine-Hsine Wu, et al.. (2020). Unique Sulfur–Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase Inhibitors. Journal of Medicinal Chemistry. 63(4). 1642–1659. 31 indexed citations
5.
Lin, Wen‐Hsing, Yi‐Hui Peng, Tsu Hsu, et al.. (2016). Pyrazolylamine Derivatives Reveal the Conformational Switching between Type I and Type II Binding Modes of Anaplastic Lymphoma Kinase (ALK). Journal of Medicinal Chemistry. 59(8). 3906–3919. 26 indexed citations
6.
Wu, Jian‐Sung, Shu‐Yu Lin, Wen‐Chi Hsiao, et al.. (2015). Identification of Substituted Naphthotriazolediones as Novel Tryptophan 2,3-Dioxygenase (TDO) Inhibitors through Structure-Based Virtual Screening. Journal of Medicinal Chemistry. 58(19). 7807–7819. 48 indexed citations
7.
Peng, Yi‐Hui, Shau‐Hua Ueng, Ming‐Shiu Hung, et al.. (2015). Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1. Journal of Medicinal Chemistry. 59(1). 282–293. 121 indexed citations
8.
Peng, Yi‐Hui, Mohane Selvaraj Coumar, Jian‐Sung Wu, et al.. (2010). Structural Basis for the Improved Potency of Peroxisome Proliferator‐Activated Receptor (PPAR) Agonists. ChemMedChem. 5(10). 1707–1716. 7 indexed citations
9.
Wu, Jian‐Sung, Yi‐Hui Peng, Szu‐Huei Wu, et al.. (2010). Discovery of Non-Glycoside Sodium-Dependent Glucose Co-Transporter 2 (SGLT2) Inhibitors by Ligand-Based Virtual Screening. Journal of Medicinal Chemistry. 53(24). 8770–8774. 23 indexed citations
10.
Lu, I-Lin, Neeraj Mahindroo, Po‐Huang Liang, et al.. (2006). Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Main Protease. Journal of Medicinal Chemistry. 49(17). 5154–5161. 117 indexed citations
11.
Mahindroo, Neeraj, Yi‐Hui Peng, Chia‐Hui Lin, et al.. (2006). Structural Basis for the Structure−Activity Relationships of Peroxisome Proliferator-Activated Receptor Agonists. Journal of Medicinal Chemistry. 49(21). 6421–6424. 25 indexed citations
12.
Lu, I-Lin, Chien-Fu Huang, Yi‐Hui Peng, et al.. (2006). Structure-Based Drug Design of a Novel Family of PPARγ Partial Agonists:  Virtual Screening, X-ray Crystallography, and in Vitro/in Vivo Biological Activities. Journal of Medicinal Chemistry. 49(9). 2703–2712. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026